Share Price | Mahamaya Lifesciences Ltd Stock Analysis & Recommendation

Q: Why is Mahamaya Lifesciences Ltd falling/rising?

As of 02-Jun, Mahamaya Lifesciences Ltd's stock price is currently at 162.55, reflecting a slight decrease of 0.1, or 0.06%. The stock has underperformed compared to the benchmark Sensex, which has declined by 1.79% over the past week, while Mahamaya's stock has fallen by 2.43%. Over the past month, the stock has seen a more significant drop of 10.69%, compared to the Sensex's decline of 2.94%. Year-to-date, Mahamaya's stock is down 11.90%, while the Sensex has decreased by 12.40%.Today's performance indicates that Mahamaya Lifesciences Ltd is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This suggests a consistent downward trend in the stock's price. Additionally, there has been a notable decline in investor participation, with delivery volume dropping by 51.92% compared to the 5-day average, indicating reduced interest from investors. Overall, the combination of underperformance against the benchmark, declining moving averages, and falling investor participation contributes to the stock's current downward movement.

Technical Trend Update: Mahamaya Lifesc. witnessed a change in Technical Grade on 01 Jun 2026. Click here to discover latest technical change!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

49.2 k (210.61%) Volume

Shareholding (Mar 2026)

FII

4.77%

Held by 4 FIIs

DII

2.52%

Held by 0 DIIs

Promoter

56.35%

When is the next results date for Mahamaya Lifesciences Ltd?

21-May-2026

The next results date for Mahamaya Lifesciences Ltd is 25 May 2026.

View full answer

Why is Mahamaya Lifesciences Ltd falling/rising?

03-Jun-2026

As of 02-Jun, Mahamaya Lifesciences Ltd's stock price is 162.55, down 0.06%. The stock has underperformed the Sensex, with significant declines over the past week, month, and year, indicating a consistent downward trend and reduced investor interest.

View full answer

Which are the latest news on Mahamaya Lifesc.?

03-Jun-2026

When is the next results date for Mahamaya Lifesciences Ltd?

Compare Mahamaya Lifesc. with Similar Stocks

Shivalik Rasayan Crop Life Scienc Best Agrolife

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pesticides & Agrochemicals

Market cap

INR 380 Cr (Micro Cap)

P/E

21.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.42

Return on Equity

13.63%

Price to Book

3.09

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-7.55%

6 Months

7.5%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Mahamaya Lifesc. for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

When is the next results date for Mahamaya Lifesciences Ltd?

The next results date for Mahamaya Lifesciences Ltd is scheduled for 25 May 2026....

Read full news article

Announcements

Announcement under Regulation 30 (LODR)-Press Release / Media Release

26-May-2026 | Source : BSE

Submission of Press Release on Audited Financial Results for FY26

The Audited (Standalone & Consolidated) Financial Results Of The Company For The Half Year And Financial Year Ended 31.03.2026 Along With The Audit Reports Thereon

25-May-2026 | Source : BSE

Audited Financial Results (Standalone & Consolidated) of the Company for the half year and financial year ended 31.03.2026 along with the Audit Reports thereon.

Board Meeting Outcome for Audited Financial Results (Standalone & Consolidated) For The Half Year And Year Ended On 31.03.2026

25-May-2026 | Source : BSE

Audited Financial Results along with Auditors Report for the half year and financial Year ended on 31st March 2026

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

3.07

Debt to EBITDA (avg)

2.69

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

1.54

Tax Ratio

30.54%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

7.30%

ROCE (avg)

18.08%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.88

EV to EBIT

12.88

EV to EBITDA

12.02

EV to Capital Employed

2.33

EV to Sales

1.23

PEG Ratio

Dividend Yield

ROCE (Latest)

18.08%

ROE (Latest)

13.63%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

No Signal

Bollinger Bands

Bearish

KST

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 4 FIIs (4.77%)

Promoter with highest holding

Krishnamurthy Ganesan (21.86%)

Highest Public shareholder

Pink Tiger Alliances Llp (10.35%)

Individual Investors Holdings

10.65%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Mahamaya Lifesc."
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Mar 2026 is 1.54% vs 11.69% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Mar 2026 is -2.63% vs 15.45% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "165.90",
          "val2": "163.39",
          "chgp": "1.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17.38",
          "val2": "15.43",
          "chgp": "12.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.29",
          "val2": "3.85",
          "chgp": "11.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8.15",
          "val2": "8.37",
          "chgp": "-2.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.48%",
          "val2": "9.46%",
          "chgp": "1.02%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Mahamaya Lifesc."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 23.91% vs 64.48% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 28.96% vs 145.40% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "329.28",
          "val2": "265.75",
          "chgp": "23.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "33.51",
          "val2": "24.41",
          "chgp": "37.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.14",
          "val2": "6.81",
          "chgp": "19.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "16.52",
          "val2": "12.81",
          "chgp": "28.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.19%",
          "val2": "9.24%",
          "chgp": "0.95%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Consolidated) - Mar'26

Mar'26

Sep'25

Change(%)

Net Sales

165.90

163.39

1.54%

Operating Profit (PBDIT) excl Other Income

17.38

15.43

12.64%

Interest

4.29

3.85

11.43%

Exceptional Items

0.00

Consolidate Net Profit

8.15

8.37

-2.63%

Operating Profit Margin (Excl OI)

10.48%

9.46%

1.02%

Values in Rs Cr.

Compare with Peers

Net Sales

Growth in half year ended Mar 2026 is 1.54% vs 11.69% in Sep 2025

Consolidated Net Profit

Growth in half year ended Mar 2026 is -2.63% vs 15.45% in Sep 2025

All Half Yearly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

329.28

265.75

23.91%

Operating Profit (PBDIT) excl Other Income

33.51

24.41

37.28%

Interest

8.14

6.81

19.53%

Exceptional Items

0.00

Consolidate Net Profit

16.52

12.81

28.96%

Operating Profit Margin (Excl OI)

10.19%

9.24%

0.95%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 23.91% vs 64.48% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 28.96% vs 145.40% in Mar 2025

All Annual Results

Company CV

About Mahamaya Lifesciences Ltd

Mahamaya Lifesciences Ltd

Micro Cap

Pesticides & Agrochemicals

Mahamaya Lifesciences Limited was originally incorporated as a private limited Company as "Mahamaya Life Sciences Private Limited" by the Assistant Registrar of Companies, NCT Delhi & Haryana, on May 07, 2002. Further, Company's name was changed from "Mahamaya Life Sciences Private Limited" to "Mahamaya Lifesciences Private Limited" dated February 15, 2016. The status was changed to Public Limited Company on November 19, 2024 by the Central Processing Centre.

Company Coordinates

No Company Details Available